Latest Acetylcholine Stories
NEW YORK, April 18, 2011 /PRNewswire/ -- What: The MG Walk is a new signature fundraising campaign designed to provide hope for the thousands of families forced to face the challenges caused by myasthenia gravis.
MINNETONKA, Minn., April 8, 2011 /PRNewswire/ -- Uroplasty, Inc.
Newcastle University scientists have identified a new gene which will allow rapid diagnosis and earlier treatment of a debilitating neuromuscular condition.
Protection against nerve gas attack is a significant component of the defense system of many countries around the world.
Targeted nerve stimulation could yield a long-term reversal of tinnitus, a debilitating hearing impairment affecting at least 10 percent of senior citizens and up to 40 percent of military veterans.
MADISON, Wis. and TOLEDO, Ohio, Jan. 11, 2011 /PRNewswire/ -- Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System disorders, including Alzheimer's disease, announces that it has secured commitments of $1.25 million in new funding.
Medical researchers have found a so-called "missing link" that explains the interaction between brain state and the neural triggers responsible for learning.
Medical researchers have found a missing link that explains the interaction between brain state and the neural triggers responsible for learning, potentially opening up new ways of boosting cognitive function in the face of diseases such as Alzheimer's as well as enhancing memory in healthy people.
The brain is forever chattering to itself, via electrical impulses sent along its hard-wired neuronal "Ethernet".
NESS ZIONA, Israel, November 9, 2010 /PRNewswire/ -- NeuroDerm, Ltd. announced today that patient enrollment has begun in a Phase 2a clinical study of ND0801, a new product for the treatment of Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder (ADD/ADHD) in adults. ND0801, based on a new, proprietary combination with nicotinic actions, is being developed as a dermal patch and will be evaluated for the treatment of cognitive impairment in several disorders including...
- A volcanic mudflow.